Table Of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Small Molecule Drug Discovery Market: Therapeutic Area Segment Trends, Size, and Future Outlook
- Therapeutic Area Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Therapeutic Area Segment Definitions, Technology Landscape
- Therapeutic Area Segment Market Drivers
- Product Launches
- Technology Launches
- Therapeutic Area Segment Market Restraints
Chapter 4. Small Molecule Drug Discovery Market: Drug Type Segment Trends, Size, and Future Outlook
- Drug Type Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Drug Type Segment Definitions, Technology Landscape
- Drug Type Segment Market Drivers
- Product Launches
- Technology Launches
- Drug Type Segment Market Restraints
Chapter 5. Small Molecule Drug Discovery Market: Target Class Segment Trends, Size, and Future Outlook
- Target Class Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Target Class Segment Definitions, Technology Landscape
- Target Class Segment Market Drivers
- Product Launches
- Technology Launches
- Target Class Segment Market Restraints
Chapter 6. Small Molecule Drug Discovery Market: Molecule Type Segment Trends, Size, and Future Outlook
- Molecule Type Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Molecule Type Segment Definitions, Technology Landscape
- Molecule Type Segment Market Drivers
- Product Launches
- Technology Launches
- Molecule Type Segment Market Restraints
Chapter 7. Small Molecule Drug Discovery Market: Phase of Development Segment Trends, Size, and Future Outlook
- Phase of Development Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Phase of Development Segment Definitions, Technology Landscape
- Phase of Development Segment Market Drivers
- Product Launches
- Technology Launches
- Phase of Development Segment Market Restraints
Chapter 8. Small Molecule Drug Discovery Market: Service Type Segment Trends, Size, and Future Outlook
- Service Type Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Service Type Segment Definitions, Technology Landscape
- Service Type Segment Market Drivers
- Product Launches
- Technology Launches
- Service Type Segment Market Restraints
Chapter 9. Small Molecule Drug Discovery Market: Technology Segment Trends, Size, and Future Outlook
- Technology Segment Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Technology Segment Definitions, Technology Landscape
- Technology Segment Market Drivers
- Product Launches
- Technology Launches
- Technology Segment Market Restraints
Chapter 10. Small Molecule Drug Discovery Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia-Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East & Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
Chapter 11. Small Molecule Drug Discovery Market: Competitive Landscape
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co., Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Roche Holding AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AstraZeneca plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AbbVie Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Boehringer Ingelheim International GmbH
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Astellas Pharma Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Daiichi Sankyo Company, Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eisai Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Otsuka Holdings Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Shionogi & Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Chugai Pharmaceutical Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Small Molecule Drug Discovery industry is estimated to be USD 35.2 billion in 2023.
Increasing prevalence of chronic diseases, Rising demand for personalized medicine, Advancements in computational drug discovery techniques, Growing pharmaceutical R&D investments, Increasing healthcare expenditure, Aging population, Sedentary lifestyles and rising obesity rates, Improved diagnostic techniques, Increased disease awareness, Development of targeted therapies
High costs of drug development, Stringent regulatory requirements for approval, Patent expiration of blockbuster drugs, Lack of skilled professionals, Pricing pressures and reimbursement challenges, Lengthy development and approval timelines, Ethical concerns and public perception
The leading component segment in the Small Molecule Drug Discovery Market is the small molecule synthetic drugs segment, which includes chemically synthesized organic compounds used for various therapeutic areas.
The major players operating in the Small Molecule Drug Discovery Market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, Sanofi, Bristol-Myers Squibb Company, and Eli Lilly and Company.
The Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.6% from 2024 to 2031, and is projected to reach a market size of USD 68.1 billion by 2031.
Increasing prevalence of chronic diseases, Rising demand for personalized medicine, Advancements in computational drug discovery techniques, Growing pharmaceutical R&D investments, Increasing healthcare expenditure, Aging population, Sedentary lifestyles and rising obesity rates, Improved diagnostic techniques